| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,250 | 1,350 | 18.11. | |
| 1,300 | 1,320 | 18.11. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| So | 4DMEDICAL LIMITED: Former ResMed CFO Brett Sandercock joins 4DMedical Board | - | ASX | ||
| So | Bis zu 286% Kurspotenzial: 5 australische Aktien, auf die Analysten jetzt setzen - und First Graphene als Außenseiter | Small- & Micro Cap Investment | |||
| Fr | 4DMEDICAL LIMITED: Application for quotation of securities - 4DX | 4 | ASX | ||
| 4DMEDICAL Aktie jetzt für 0€ handeln | |||||
| 05.11. | 4DMedical (ASX:4DX) Can a Great Product Still Be a Bad Investment at This Price (HOLD) | 4 | Stocks Down Under | ||
| 04.11. | 4DMEDICAL LIMITED: Becoming a substantial holder | 15 | ASX | ||
| 03.11. | 4DMedical Shares Volatile Amidst Governance Rift | 3 | Finance News Network | ||
| 02.11. | 4DMEDICAL LIMITED: Response to ASX Price Query | 3 | ASX | ||
| 01.11. | 4DMEDICAL LIMITED: Pause in Trading | 2 | ASX | ||
| 28.10. | 4DMEDICAL LIMITED: Results of AGM | 4 | ASX | ||
| 27.10. | 4DMEDICAL LIMITED: Quarterly Activity Report and Appendix 4C | 4 | ASX | ||
| 27.10. | 4DMEDICAL LIMITED: AGM Presentation and Chair's address | 2 | ASX | ||
| 23.10. | 4DMEDICAL LIMITED: Notice of 2026 Annual General Meeting - Clarification | 1 | ASX | ||
| 16.10. | 4DMEDICAL LIMITED: Application for quotation of securities - 4DX | 1 | ASX | ||
| 16.10. | 4DMEDICAL LIMITED: Addendum to 2026 Notice of Annual General Meeting | 1 | ASX | ||
| 02.10. | 4DMEDICAL LIMITED: Notification of cessation of securities - 4DX | 10 | ASX | ||
| 28.09. | 4DMEDICAL LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 25.09. | 4DMEDICAL LIMITED: Becoming a substantial holder | 1 | ASX | ||
| 24.09. | 4DMedical Ltd Full Year Sales Increase | 1 | RTTNews | ||
| 24.09. | 4DMEDICAL LIMITED: Notice of Annual General Meeting/Proxy Form | 1 | ASX | ||
| 24.09. | 4DMEDICAL LIMITED: Appendix 4G and Corporate Governance Statement | 1 | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,424 | -3,83 % | Truist raises Teladoc stock price target to $9 on EBITDA outlook | ||
| SERNOVA BIOTHERAPEUTICS | 0,066 | -1,50 % | Sernova Biotherapeutics-Aktie 19,8 % im Minus: 11,2 Millionen für die Fusion mit Seraxis | ||
| CERENOME | 0,474 | -27,04 % | Cerenome outlines $10M-$12.5M 2026 gross billings run rate exit while targeting mid-2027 REYOBIQ top line data | ||
| ATOSSA THERAPEUTICS | 1,680 | -2,89 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Rekord bei Umsatz und Gewinn - lächerliche Bewertung! | Sonoma Pharmaceuticals macht den nächsten gewaltigen Schritt auf dem Weg zum profitablen Wachstumsunternehmen. Nach dem erstmaligen Erreichen eines positiven EBITDA im Vorquartal meldet der Healthcare-Spezialist... ► Artikel lesen | |
| TANDEM DIABETES | 16,100 | +3,87 % | Warum die Aktie von Tandem Diabetes Care heute kräftig zulegt | ||
| CO-DIAGNOSTICS | 0,197 | 0,00 % | Co-Diagnostics receives test order from Peru amid dengue rise | ||
| QUIDELORTHO | 8,994 | +0,22 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,300 | +7,98 % | Veru presents data on enobosarm for obesity treatment | ||
| LIFEWARD | 3,200 | 0,00 % | Lifeward GAAP EPS of -$1.32 misses by $0.50, revenue of $5.43M misses by $1.81M | ||
| CLOVER HEALTH INVESTMENTS | 3,870 | -9,79 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| SENSEONICS | 9,400 | +1,62 % | Senseonics Holdings, Inc.: Senseonics and Beta Bionics Launch Eversense 365 and iLet Bionic Pancreas Integration | ||
| TEMPEST THERAPEUTICS | 0,310 | -5,44 % | Tempest Therapeutics GAAP EPS of -$0.21 beats by $0.11 | ||
| NANO-X IMAGING | 0,263 | -8,45 % | NANO-X IMAGING LTD: Nanox to Showcase Its Innovative Technology and Advances Across Nanox.ARC X and Nanox.AI at RSNA 2026 | ||
| IMUNON | 0,440 | +0,46 % | Imunon targets 50% OVATION-3 enrollment in Q1 2028 while aiming for interim analysis in Q1 2030 |